Robenacoxib
From Wikipedia, the free encyclopedia
![]() |
|
Names | |
---|---|
IUPAC name
{5-Ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid
|
|
Identifiers | |
3D model (Jmol) | Interactive image |
ChEBI | CHEBI:76269 |
ChemSpider | 4938295 |
PubChem | 6433107 |
|
|
|
|
Properties | |
C16H13F4NO2 | |
Molar mass | 327.28 g·mol−1 |
Pharmacology | |
QM01AH91 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Robenacoxib (Onsior) is a non-steroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.[1]
References[edit]
- ^ "Onsior (Robenacoxib)". Novartis Animal Health.
![]() |
This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it. |
![]() |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |